Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bencycloquidium bromide nasal spray after transnasal nasopharyngeal surgery
ChiCTR2600135533Phase 4Completed
- Sponsor
- Zunyi Medical University Affiliated Hospital
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of Bencycloquidium bromide in Eustachian tube dysfunction (ETD) (3 arms), sponsored by Zunyi Medical University Affiliated Hospital. Primary endpoints: Athens Insomnia Scale score, Nasal endoscopic DIP score and 1 more. Started Nov 2024; status: completed.
02
Drugs
Bencycloquidium bromide
03
Conditions
Eustachian tube dysfunction (ETD)
Beyond the preview
Go deeper on ChiCTR2600135533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600135533.